Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb. Our analysis of options history for Bristol-Myers Squibb BMY revealed 8 unusual trades.
Delving into the details, we found 25% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $307,804, and 4 were calls, valued at $200,253.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $43.0 to $55.0 for Bristol-Myers Squibb over the last 3 months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Bristol-Myers Squibb's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bristol-Myers Squibb's whale activity within a strike price range from $43.0 to $55.0 in the last 30 days.
Bristol-Myers Squibb 30-Day Option Volume & Interest Snapshot
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | PUT | SWEEP | BEARISH | 10/18/24 | $7.5 | $7.4 | $7.5 | $55.00 | $107.2K | 667 | 143 |
| BMY | PUT | TRADE | BEARISH | 06/20/25 | $3.6 | $3.4 | $3.52 | $45.00 | $105.6K | 1.2K | 0 |
| BMY | CALL | SWEEP | BULLISH | 10/18/24 | $7.3 | $7.15 | $7.25 | $43.00 | $90.6K | 60 | 126 |
| BMY | PUT | SWEEP | BEARISH | 10/18/24 | $7.5 | $7.4 | $7.5 | $55.00 | $65.2K | 667 | 230 |
| BMY | CALL | SWEEP | NEUTRAL | 05/17/24 | $0.99 | $0.98 | $0.98 | $50.00 | $56.7K | 7.6K | 1.2K |
About Bristol-Myers Squibb
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
Following our analysis of the options activities associated with Bristol-Myers Squibb, we pivot to a closer look at the company's own performance.
Current Position of Bristol-Myers Squibb
- Currently trading with a volume of 5,739,707, the BMY's price is up by 1.38%, now at $48.97.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 6 days.
What The Experts Say On Bristol-Myers Squibb
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $52.0.
- Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for Bristol-Myers Squibb, targeting a price of $52.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Bristol-Myers Squibb with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
